lipoxin a4 has been researched along with Parasitemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Castillo, C; Cramer, A; González-Herrera, F; Kemmerling, U; Liempi, A; Machado, FS; Maya, JD; Pimentel, P | 1 |
Arantes, RM; Araujo, RR; Barroso, A; Brant, F; Campos, CF; Castro, LL; Cruz, JS; Esper, L; Gomes, ER; Guatimosim, S; Lara, A; Lisanti, MP; Machado, FS; Mukherjee, S; Ramos, IP; Rocha, NN; Roman-Campos, D; Tanowitz, HB; Teixeira, MM; Vieira, LQ; Weiss, LM | 1 |
2 other study(ies) available for lipoxin a4 and Parasitemia
Article | Year |
---|---|
Simvastatin Attenuates Endothelial Activation through 15-Epi-Lipoxin A4 Production in Murine Chronic Chagas Cardiomyopathy.
Topics: Animals; Anticholesteremic Agents; Arachidonate 5-Lipoxygenase; Chagas Cardiomyopathy; Chronic Disease; Disease Models, Animal; Drug Therapy, Combination; E-Selectin; Endothelium; Gene Expression Regulation; Humans; Intercellular Adhesion Molecule-1; Lipoxins; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Myocardium; Nitroimidazoles; Parasitemia; Simvastatin; Survival Analysis; Trypanocidal Agents; Trypanosoma cruzi; Vascular Cell Adhesion Molecule-1 | 2017 |
Role of SOCS2 in modulating heart damage and function in a murine model of acute Chagas disease.
Topics: Acute Disease; Animals; Arachidonate 5-Lipoxygenase; Cells, Cultured; Chagas Cardiomyopathy; Cytokines; Disease Models, Animal; Heart; Lipoxins; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Parasite Load; Parasitemia; Patch-Clamp Techniques; Suppressor of Cytokine Signaling Proteins; T-Lymphocyte Subsets; Trypanosoma cruzi | 2012 |